Clinical Trial Update: Safety and Efficacy of Autologous Adipose-Derived Stem Cell Transplantation in Patients With Type 1 Diabetes [Phase 1, Phase 2]

View source ↗

Summary

This clinical trial update reports on the safety and potential efficacy of autologous adipose-derived stem cell transplantation in patients with Type 1 diabetes…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 1 Diabetes Mellitus

Drugs mentioned

• Autologous adipose-derived stem cell transplantation

Snippet

Sponsor: Adistem Ltd | Conditions: Type 1 Diabetes Mellitus | Phase 1, Phase 2 | Status: UNKNOWN